A phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans

  • Comeau, Jeannette Louise (PI)
  • Gauvreau, Gail M G.M. (CoPI)
  • Halperin, Scott Alan S.A. (CoPI)
  • Langley, Joanne Marie J.M. (CoPI)
  • Loeb, Mark Bertram M.B. (CoPI)
  • Miller, Matthew S M.S. (CoPI)
  • Satia, I. (CoPI)
  • Smaill, Fiona Mary F. (CoPI)
  • Wang, Jun (CoPI)
  • Xing, Zhou (CoPI)
  • Afkhami, Sam S. (CoPI)
  • Cameron, D. William D.W. (CoPI)
  • D'agostino, Michael R M.R. (CoPI)
  • Dionne, Marc S. (CoPI)
  • Gillgrass, Amy E A.E. (CoPI)
  • Halperin, Donna Marie (CoPI)
  • Jamali, Saeideh S. (CoPI)
  • Jeyanathan, Mangalakumari M. (CoPI)
  • Lichty, Brian Dennis B. (CoPI)
  • Liu, Jinghua J. (CoPI)
  • Mertz, D. (CoPI)
  • Parsons Leigh, Jeanna Joanne (CoPI)
  • Smieja, M. (CoPI)
  • Thabane, Lehana (CoPI)

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/22 → 8/31/25

ASJC Scopus Subject Areas

  • Immunology
  • Infectious Diseases

Access Project